AFP and hepatocellular carcinoma: MDK was detected in 95% of patients before treatment and decreased after treatment to 67%. MDK was associated with tumor number and size, vascular invasion, and clinical stage. Patients with positive MDK before intervention were more likely to relapse compared with those without MDK expression.MDK expression was detected in 83% of patients with early-stage AFP-negative HCC.